Woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desmin

BackgroundDisordered and hypomineralized woven bone formation by dysfunctional mesenchymal stromal cells (MSCs) characterize delayed fracture healing and endocrine –metabolic bone disorders like fibrous dysplasia and Paget disease of bone. To shed light on molecular players in osteoblast differentia...

Full description

Bibliographic Details
Main Authors: Giusy Di Conza, Fulvio Barbaro, Nicoletta Zini, Giulia Spaletta, Giulia Remaggi, Lisa Elviri, Salvatore Mosca, Silvio Caravelli, Massimiliano Mosca, Roberto Toni
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1234569/full
_version_ 1797693153991458816
author Giusy Di Conza
Fulvio Barbaro
Nicoletta Zini
Nicoletta Zini
Giulia Spaletta
Giulia Remaggi
Lisa Elviri
Salvatore Mosca
Silvio Caravelli
Massimiliano Mosca
Roberto Toni
Roberto Toni
Roberto Toni
Roberto Toni
author_facet Giusy Di Conza
Fulvio Barbaro
Nicoletta Zini
Nicoletta Zini
Giulia Spaletta
Giulia Remaggi
Lisa Elviri
Salvatore Mosca
Silvio Caravelli
Massimiliano Mosca
Roberto Toni
Roberto Toni
Roberto Toni
Roberto Toni
author_sort Giusy Di Conza
collection DOAJ
description BackgroundDisordered and hypomineralized woven bone formation by dysfunctional mesenchymal stromal cells (MSCs) characterize delayed fracture healing and endocrine –metabolic bone disorders like fibrous dysplasia and Paget disease of bone. To shed light on molecular players in osteoblast differentiation, woven bone formation, and mineralization by MSCs we looked at the intermediate filament desmin (DES) during the skeletogenic commitment of rat bone marrow MSCs (rBMSCs), where its bone-related action remains elusive.ResultsMonolayer cultures of immunophenotypically- and morphologically - characterized, adult male rBMSCs showed co-localization of desmin (DES) with vimentin, F-actin, and runx2 in all cell morphotypes, each contributing to sparse and dense colonies. Proteomic analysis of these cells revealed a topologically-relevant interactome, focused on cytoskeletal and related enzymes//chaperone/signalling molecules linking DES to runx2 and alkaline phosphatase (ALP). Osteogenic differentiation led to mineralized woven bone nodules confined to dense colonies, significantly smaller and more circular with respect to controls. It significantly increased also colony-forming efficiency and the number of DES-immunoreactive dense colonies, and immunostaining of co-localized DES/runx-2 and DES/ALP. These data confirmed pre-osteoblastic and osteoblastic differentiation, woven bone formation, and mineralization, supporting DES as a player in the molecular pathway leading to the osteogenic fate of rBMSCs.ConclusionImmunocytochemical and morphometric studies coupled with proteomic and bioinformatic analysis support the concept that DES may act as an upstream signal for the skeletogenic commitment of rBMSCs. Thus, we suggest that altered metabolism of osteoblasts, woven bone, and mineralization by dysfunctional BMSCs might early be revealed by changes in DES expression//levels. Non-union fractures and endocrine – metabolic bone disorders like fibrous dysplasia and Paget disease of bone might take advantage of this molecular evidence for their early diagnosis and follow-up.
first_indexed 2024-03-12T02:39:29Z
format Article
id doaj.art-8e8c6d530014497da7c8b89b468d21bd
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-03-12T02:39:29Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-8e8c6d530014497da7c8b89b468d21bd2023-09-04T09:23:14ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-09-011410.3389/fendo.2023.12345691234569Woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desminGiusy Di Conza0Fulvio Barbaro1Nicoletta Zini2Nicoletta Zini3Giulia Spaletta4Giulia Remaggi5Lisa Elviri6Salvatore Mosca7Silvio Caravelli8Massimiliano Mosca9Roberto Toni10Roberto Toni11Roberto Toni12Roberto Toni13Department of Medicine and Surgery - DIMEC, Unit of Biomedical, Biotechnological and Translational Sciences (S.BI.BI.T.), Laboratory of Regenerative Morphology and Bioartificial Structures (Re.Mo.Bio.S.), and Museum and Historical Library of Biomedicine - BIOMED, University of Parma, Parma, ItalyDepartment of Medicine and Surgery - DIMEC, Unit of Biomedical, Biotechnological and Translational Sciences (S.BI.BI.T.), Laboratory of Regenerative Morphology and Bioartificial Structures (Re.Mo.Bio.S.), and Museum and Historical Library of Biomedicine - BIOMED, University of Parma, Parma, ItalyUnit of Bologna, National Research Council of Italy (CNR) Institute of Molecular Genetics “Luigi Luca Cavalli-Sforza”, Bologna, ItalyIRCCS Istituto Ortopedico Rizzoli, Bologna, ItalyDepartment of Statistical Sciences, University of Bologna, Bologna, ItalyFood and Drug Department, University of Parma, Parma, ItalyFood and Drug Department, University of Parma, Parma, ItalyCourse on Disorders of the Locomotor System, Fellow Program in Orthopaedics and Traumatology, University Vita-Salute San Raffaele, Milan, ItalyII Clinic of Orthopedic and Traumatology, IRCCS Istituto Ortopedico Rizzoli, Bologna, ItalyII Clinic of Orthopedic and Traumatology, IRCCS Istituto Ortopedico Rizzoli, Bologna, ItalyDepartment of Medicine and Surgery - DIMEC, Unit of Biomedical, Biotechnological and Translational Sciences (S.BI.BI.T.), Laboratory of Regenerative Morphology and Bioartificial Structures (Re.Mo.Bio.S.), and Museum and Historical Library of Biomedicine - BIOMED, University of Parma, Parma, ItalyEndocrinology, Diabetes, and Nutrition Disorders Outpatient Clinic, Osteoporosis, Nutrition, Endocrinology, and Innovative Therapies (OSTEONET) Unit, Galliera Medical Center (GMC), San Venanzio di Galliera, BO, ItalySection IV - Medical Sciences, Academy of Sciences of the Institute of Bologna, Bologna, Italy0Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center - Tufts University School of Medicine, Boston, MA, United StatesBackgroundDisordered and hypomineralized woven bone formation by dysfunctional mesenchymal stromal cells (MSCs) characterize delayed fracture healing and endocrine –metabolic bone disorders like fibrous dysplasia and Paget disease of bone. To shed light on molecular players in osteoblast differentiation, woven bone formation, and mineralization by MSCs we looked at the intermediate filament desmin (DES) during the skeletogenic commitment of rat bone marrow MSCs (rBMSCs), where its bone-related action remains elusive.ResultsMonolayer cultures of immunophenotypically- and morphologically - characterized, adult male rBMSCs showed co-localization of desmin (DES) with vimentin, F-actin, and runx2 in all cell morphotypes, each contributing to sparse and dense colonies. Proteomic analysis of these cells revealed a topologically-relevant interactome, focused on cytoskeletal and related enzymes//chaperone/signalling molecules linking DES to runx2 and alkaline phosphatase (ALP). Osteogenic differentiation led to mineralized woven bone nodules confined to dense colonies, significantly smaller and more circular with respect to controls. It significantly increased also colony-forming efficiency and the number of DES-immunoreactive dense colonies, and immunostaining of co-localized DES/runx-2 and DES/ALP. These data confirmed pre-osteoblastic and osteoblastic differentiation, woven bone formation, and mineralization, supporting DES as a player in the molecular pathway leading to the osteogenic fate of rBMSCs.ConclusionImmunocytochemical and morphometric studies coupled with proteomic and bioinformatic analysis support the concept that DES may act as an upstream signal for the skeletogenic commitment of rBMSCs. Thus, we suggest that altered metabolism of osteoblasts, woven bone, and mineralization by dysfunctional BMSCs might early be revealed by changes in DES expression//levels. Non-union fractures and endocrine – metabolic bone disorders like fibrous dysplasia and Paget disease of bone might take advantage of this molecular evidence for their early diagnosis and follow-up.https://www.frontiersin.org/articles/10.3389/fendo.2023.1234569/fulldesminintermediate filamentscytoskeletonmesenchymal stromal cellswoven boneosteogenesis
spellingShingle Giusy Di Conza
Fulvio Barbaro
Nicoletta Zini
Nicoletta Zini
Giulia Spaletta
Giulia Remaggi
Lisa Elviri
Salvatore Mosca
Silvio Caravelli
Massimiliano Mosca
Roberto Toni
Roberto Toni
Roberto Toni
Roberto Toni
Woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desmin
Frontiers in Endocrinology
desmin
intermediate filaments
cytoskeleton
mesenchymal stromal cells
woven bone
osteogenesis
title Woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desmin
title_full Woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desmin
title_fullStr Woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desmin
title_full_unstemmed Woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desmin
title_short Woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desmin
title_sort woven bone formation and mineralization by rat mesenchymal stromal cells imply increased expression of the intermediate filament desmin
topic desmin
intermediate filaments
cytoskeleton
mesenchymal stromal cells
woven bone
osteogenesis
url https://www.frontiersin.org/articles/10.3389/fendo.2023.1234569/full
work_keys_str_mv AT giusydiconza wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT fulviobarbaro wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT nicolettazini wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT nicolettazini wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT giuliaspaletta wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT giuliaremaggi wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT lisaelviri wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT salvatoremosca wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT silviocaravelli wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT massimilianomosca wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT robertotoni wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT robertotoni wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT robertotoni wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin
AT robertotoni wovenboneformationandmineralizationbyratmesenchymalstromalcellsimplyincreasedexpressionoftheintermediatefilamentdesmin